• Afatinib in Patient-Derived Gastric Cancer Assembloids

  2026-09-22

  A translational framework for using Afatinib, also known as BIBW 2992, to distinguish tumor-intrinsic ErbB dependence from stromal modulation in patient-derived gastric cancer assembloids.

• Mc-Val-Cit-PABC-PNP ADC Linker Protocol

  2026-09-21

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for antibody-drug conjugate synthesis workflows that require a lysosomal payload-release design. It is suited to DMSO-compatible research handling, but its water and ethanol insolubility makes it unsuitable for aqueous formulations, diagnostic use, or clinical and therapeutic applications.

• NamiRNA Dual-Pathway Control in Pancreatic Cancer

  2026-09-21

  Yu et al. show that miR-200c suppresses pancreatic cancer through two mechanistically distinct routes: nuclear activation of PTPN6 transcription through an enhancer and post-transcriptional repression of CDH17. LNP delivery extended these findings into a preclinical therapeutic model, while the study design provides a framework for separating proliferation, migration, enhancer activity, and delivery effects.

• Faropenem Sodium: Translational Leverage in AMR

  2026-09-20

  Faropenem sodium offers translational researchers a distinctive way to connect penem-mediated cell wall disruption with renal transporter biology, antimicrobial susceptibility, and resistance-focused experimental design. This article examines the mechanistic evidence, practical workflow considerations, competitive positioning, and limitations that determine its value in advanced infection research.

• GDC-0941 Workflow for PI3K/Akt Assays

  2026-09-19

  Build a robust GDC-0941 workflow that connects acute PI3K/Akt pathway inhibition with proliferation, apoptosis, and resistance phenotypes. The approach also adapts lessons from pancreatic cancer research to prevent pathway assays from being overinterpreted as simple viability tests.

• Caspase-8 Fluorometric Assay Kit Workflow

  2026-09-18

  Build a sensitive caspase-8 activity workflow for apoptosis, combination-therapy, and cell-death studies. This guide combines IETD-AFC fluorescence with treatment controls and orthogonal validation to distinguish pathway activation from nonspecific cell loss.

• ZIF8 Nanotheranostics for Ultrasound-Guided TNBC

  2026-09-18

  Li et al. developed FA-PEG@ZIF8@CIP, a folic acid- and polyethylene glycol-functionalized ZIF-8 nanoplatform that combines ultrasound imaging, sonodynamic therapy, chemotherapy, and immune activation for triple-negative breast cancer. The study links ultrasound-enhanced reactive oxygen species production with immunogenic cell death and increased cytotoxic T-cell infiltration, while also identifying practical limitations for translating the system beyond its preclinical model.

• 11β-HSD1, Notch, and NK Cells in Liver Fibrosis

  2026-09-17

  A 2025 mouse study shows that inhibiting 11β-HSD1 reduces thioacetamide-induced liver fibrosis through coordinated suppression of Notch signaling and enhancement of natural killer cell responses. The findings connect intrahepatic cortisol regulation with hepatic stellate cell activity and immune-mediated clearance, while also defining important limits for translation to MASLD and MASH research.

• Carbapenemase Transmission in Enterobacter cloacae

  2026-09-17

  A 2025 BMC Microbiology study integrated gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and strain typing to investigate carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its central finding was that blaNDM-1 was frequently plasmid-associated and highly transferable, linking multidrug resistance with both horizontal and clonal dissemination risks.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows

  2026-09-16

  IWR-1-endo enables controlled pathway perturbation across colorectal cancer, stem-cell, regeneration, and exploratory cardiac assays. This practical guide links Axin-complex stabilization to reproducible dosing, morphology profiling, β-catenin readouts, and troubleshooting.

• Meropenem Workflows for Resistance Research

  2026-09-16

  Build reproducible Meropenem assays for susceptibility testing, resistance dynamics, and Gram-negative infection models. This workflow-centered guide connects PBP biology with plasmid-transmission analysis, formulation comparisons, and septicemia treatment research while keeping exploratory findings separate from clinical interpretation.

• 2,2,2-Trichloroethanol for Protein Analysis

  2026-09-15

  Use 2,2,2-Trichloroethanol as a flexible protein analysis reagent for electrophoresis, assay development, and molecular biology research. Its water, ethanol, and DMSO solubility supports practical screening, while DAT-imaging research shows why orthogonal protein-level validation matters in translational workflows.

• Phosbind Acrylamide for Mechanism-Driven Phospho Assays

  2026-09-15

  Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis by converting phosphate-dependent binding into an SDS-PAGE mobility readout. This article explains how to use the reagent strategically when studying EV71 host-factor biology, while distinguishing protein phosphorylation from PI4P lipid signaling.

• Annexin A7, TIA1 Trafficking, and Axonal Protection

  2026-09-14

  The reference study identifies Annexin A7 as a calcium-sensitive regulator that helps couple TIA1-containing ribonucleoprotein granules to cytoplasmic dynein for retrograde axonal transport. Its findings connect impaired RNA granule trafficking with pathological TIA1 aggregation, axonopathy, and neurodegeneration, providing a mechanistic framework for studying how transport failure contributes to disease.

• Septin4, VHL, and HIF-1α in Cardiac Hypoxia

  2026-09-14

  The reference study identifies HIF-1α as a previously unrecognized Septin4-interacting protein in hypoxia-stressed cardiomyocytes. Its data indicate that Septin4 strengthens VHL-dependent HIF-1α degradation, reducing a protective hypoxic response and intensifying apoptosis, while also defining experimental considerations for studying oxygen-sensing pathways.

8305 records 1/554 page Next 12345 下5页 Last page